Profile data is unavailable for this security.
About the company
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.
- Revenue in USD (TTM)40.23bn
- Net income in USD6.40bn
- LocationAbbott Laboratories100 Abbott Park RdABBOTT PARK 60064-3500United StatesUSA
- Phone+1 (224) 667-6100
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|ABT:NYQ since |
|Walk Vascular LLC||Deal completed||02 Sep 2021||02 Sep 2021Deal completed||-7.78%||--|